Top 10 Long Term Companies To Watch In Right Now

China has been the talk of the markets this week. Monday's news that Chinese banks were facing a cash crunch sent the Shanghai Composite down 5.3% and both European and U.S. markets followed suit. But on Tuesday, China's central bank appeared to shore up some financial institutions with liquidity and both the Dow Jones Industrial Average (DJINDICES: ^DJI  ) and S&P 500 (SNPINDEX: ^GSPC  ) were primed for a recovery. By the end of the week, both the Dow and S&P 500 were up. �

China makes the world go round
The reason markets are so concerned about Chinese banks is the impact the country has on the global economy. While the U.S. has been stuck with anemic growth and Europe has been in a recession, China has been growing at nearly double digits since the financial crisis. �

A liquidity crisis in China right now may look very similar to the one in the U.S. in late 2008. If rates rise too quickly, the housing market could collapse, businesses would stop investing, and growth could quickly turn into contraction. Housing is particularly concerning because many have predicted a bubble in Chinese housing and the government has been taking efforts to curb the rise in home prices. Home prices are up double digits in China over the past year, a rate that's unsustainable long term. The housing boom is like kindling in a financial crisis.

Top Gas Companies To Buy Right Now: Threshold Pharmaceuticals Inc.(THLD)

Threshold Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and development of drugs targeting the microenvironment of solid tumors for patients living with cancer. The company?s products include TH-302, a novel drug candidate which is in Phase 1, Phase 1/2, and Phase 2 clinical trials for cancer. It has a license agreement with Eleison Pharmaceuticals, Inc. to develop and commercialize glufosfamide for the treatment of cancer in humans and animals. The company was founded in 2001 and is headquartered in Redwood City, California.

Advisors' Opinion:

• [By James E. Brumley]

  Stocks as a whole haven't gotten the new year off on the best foot, but that's not to say every equity out there is in trouble. Indeed, some small cap stocks may actually be doing well - and poised to do well for a while - specifically because larger companies are seeing their stocks struggle. To that end, traders looking for a bullish bright spot to start the new year may want to take a closer look at Amedica Corporation (NASDAQ:AMDA), Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), and Aethlon Medical, Inc. (OTCMKTS:AEMD).

Top 10 Long Term Companies To Watch In Right Now: Jack Henry & Associates Inc.(JKHY)

Jack Henry & Associates, Inc. (JHA) provides integrated computer systems and services for in-house and outsourced data processing to commercial banks, credit unions, and other financial institutions primarily in the United States. It engages in processing transactions, automating business processes, and managing information services. The company?s Jack Henry Banking brand provides integrated data processing systems to de novo or start-up institutions and mid-tier banks, as well as markets three core banking software systems, such as SilverLake, a robust IBM i-based system designed for commercial-focused banks; CIF 20/20, a parameter-driven and easy-to-use system; and Core Director, a Windows-based and client/server system that offers intuitive point-and-click operation. Its Symitar brand supports credit unions with information and transaction processing platforms that provide enterprise-wide automation. This brand?s solutions include Episys, a robust IBM p-based system p rimarily designed for credit unions; and Cruise, a Windows-based and client/server system for credit unions. The company?s ProfitStars brand provides specialized products and services that enhance the performance of financial service organizations and corporate entities. Its iPay Technologies brand operates as an electronic bill pay for banks and credit unions with turnkey, and configurable retail and small business electronic payment platforms. JHA also offers complementary solutions comprising business intelligence and bank management, retail and business banking, member and member business services, Internet banking and electronic funds transfer, risk management and protection, and item and document imaging solutions. In addition, it provides data conversion, software implementation, training, and support services, as well as sells hardware systems. The company has strategic relationship with IBM Corporation. JHA was founded in 1969 and is based in Monett, Missouri.

Advisors' Opinion:

• [By Jay Jenkins]

  It doesn't matter if the bank is a mega bank like Bank of America (NYSE: BAC  ) , a regional player like BB&T (NYSE: BBT  ) , or a third-party software provider like Jack Henry and Associates (NASDAQ: JKHY  ) , the capabilities and usability of online banking services are noticeably stuck in the mud.�

• [By Jay Jenkins]

  For U.S. Bancorp, a fine of this magnitude is nothing more than a slap on the wrist. However, it is a harbinger for change in how regulators view third-party relationships. Banks will now have to think long and hard about outsourcing, even to reputable companies like Jack Henry and Associates (NASDAQ: JKHY  ) and Fiserv (NASDAQ: FISV  ) .�

• [By Seth Jayson]

  Margins matter. The more Jack Henry & Associates (Nasdaq: JKHY  ) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why we check up on margins at least once a quarter in this series. I'm looking for the absolute numbers, so I can compare them to current and potential competitors, and any trend that may tell me how strong Jack Henry & Associates's competitive position could be.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Jack Henry & Associates (Nasdaq: JKHY  ) , whose recent revenue and earnings are plotted below.

Top 10 Long Term Companies To Watch In Right Now: PDL BioPharma Inc.(PDLI)

PDL BioPharma, Inc. engages in intellectual property asset management and royalty bearing assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.

Advisors' Opinion:

• [By Brian Orelli]

  PDL BioPharma (NASDAQ: PDLI  ) did much better with the spin out of its development stage program into Facet Biotech. The biotech started trading at $13�per share, and was eventually taken out by Abbott for $27. The main assets now reside in Abbott's aforementioned spinout AbbVie in conjunction with Biogen Idec, which was developing the drugs with PDL. If the drugs are successful, maybe the duo will spin them out into a joint venture, completing the cycle?

• [By John Reese]

  Indeed, in 2013, the Greenblatt-based portfolio has bounced back strong, returning more than 50%. Below is a look at its current holdings.

  EBIX, Inc. (EBIX)
  
  Western Refining (WNR)
  
  DirecTV (DTV)
  
  ITT Educational Services (ESI)
  
  Science Applications International (SAIC)
  
  Weight Watchers International (WTW)
  
  ConocoPhillips (COP)
  
  AmSurg Corp. (AMSG)
  
  PDL BioPharma (PDLI)
  
  AFC Enterprises (AFCE)
  
  

  Subscribe to Validea here��/p>

• [By Matthew Indyke and Brian Zen]

  Four of Klarman�� stocks include PDLBioPharma (PDLI), Ituran Location and Control (ITRN), BP (BP), and Microsoft (MSFT). What these companies have in common are annually increasing total revenues, annually increasing cash flows, and gradually decreasing operating expenses and debt. Additionally, they show a clear value focus with P/E ratios no greater than 15. And even when stocks like these go through a troubling period brought on by a sagging economy or major scandal, they have an ability to bounce back.

• [By Rebecca McClay]

  Finally, PDL BioPharma Inc. (Nasdaq: PDLI) expects third-quarter revenue of about $97 million, as compared with actual revenue of $85 million for the third quarter last year, an approximate 14% increase. Analysts expect revenue of $97.9 million.

Top 10 Long Term Companies To Watch In Right Now: (NWBO)

Northwest Biotherapeutics, Inc., a development stage biotechnology company, engages in the discovery, development, and commercialization of immunotherapy products that generate and enhance immune system responses to treat cancer in the United States. Its technology platforms comprise dendritic cell-based cancer vaccines (DCVax) and monoclonal antibodies for cancer therapeutics. The company?s product candidates include DCVax-Prostate for the treatment of non-metastatic hormone independent prostate cancer, which cleared Phase III clinical trial; DCVax-Brain that is in Phase II clinical trial for the treatment of glioblastoma multiforme; and DCVax-LB, which cleared Phase I clinical trial for the treatment of non-small cell lung cancer. Its product candidates also comprise DCVax-Direct that cleared Phase I clinical trial for the treatment of ovarian, head, and neck cancer; and DCVax-L, which completed Phase I/II clinical trials for the treatment of resectable solid tumors. In addition, the company develops CXCR4 antibodies, which are involved in various phases of disease progression, including proliferation of the primary tumor, migration of cancer cells out of the primary tumor, and establishment of distant metastatic sites for the treatment of non-small cell lung cancer, breast cancer, glioblastoma multiforme, colon cancer, melanoma, prostate, pancreatic, kidney, ovarian, and certain blood cancers. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.

Advisors' Opinion:

• [By Smith On Stocks]

  Using my assumptions, the common of Agenus might be worth about $7.00 per share in early 2014 based on the royalties from the Glaxo vaccines and the net operating loss carry forward even if every other asset in the company were valued at zero. However, there may be substantial value in Agenus' internal vaccine programs in recurrent and newly diagnosed glioblastoma and the genital herpes vaccine. Based on a comparison to peer companies like Northwest Biotherapeutics (NWBO) and ImmunoCellular Therapeutics (IMUC), I believe that the internal programs at Agenus currently may be worth $150 million or $4.45 per share. Adding this to the value of the MAGE A-3 vaccine could produce a stock price of $11.00 in early 2014.

Top 10 Long Term Companies To Watch In Right Now: E.I. du Pont de Nemours and Company(DD)

E. I. du Pont de Nemours and Company operates as a science and technology company worldwide. It operates in seven segments: Agriculture & Nutrition, Electronics & Communications, Performance Chemicals, Performance Coatings, Performance Materials, Safety & Protection, and Pharmaceuticals. The Agriculture & Nutrition segment provides hybrid seed corn and soybean seed, herbicides, fungicides, insecticides, value enhanced grains, and soy protein under the Pioneer brand name. The Electronics & Communications segment supplies materials and systems for photovoltaic products, consumer electronics, displays, and advanced printing. The Performance Chemicals segment offers fluorochemicals, fluoropolymers, specialty and industrial chemicals, and white pigments for various markets, such as plastics and coatings, textiles, mining, pulp and paper, water treatment, and healthcare. The Performance Coatings segment supplies high performance liquid and powder coatings for motor vehicle origi nal equipment manufacturers (OEM); the motor vehicle after-market; and general industrial applications, such as such as coatings for heavy equipment, pipes and appliances, and electrical insulation. The Performance Materials segment provides polymers, elastomers, films, parts, and systems and solutions for the automotive OEM and associated after-market industries, as well as electrical, electronics, packaging, construction, oil, photovoltaics, aerospace, chemical processing, and consumer durable goods. The Safety & Protection segment primarily offers nonwovens, aramids, and solid surfaces for the construction, transportation, communications, industrial chemicals, oil and gas, electric utilities, automotive, manufacturing, defense, homeland security, and safety consulting industries. The Pharmaceuticals segment represents its interest in the collaboration relating to Cozaar/Hyzaar antihypertensive drugs. The company was founded in 1802 and is headquartered in Wilmington, Dela ware.

Advisors' Opinion:

• [By Dan Carroll]

  DuPont (NYSE: DD  ) also topped expectations today, and the stock sits atop the Dow so far with gains of 3.5%. The firm's net income climbed 6% year over year to $1.58 per share. A 14% increase in agricultural sales helped to offset the company's lagging performance-chemical business.

• [By MONEYMORNING.COM]

  Meanwhile, Peltz has turned up the heat in his campaign to drive E. I. Du Pont De Nemours and Co. (NYSE: DD) to break up.

  Historically, retail investors have struggled to profit from these moves, because by the time they become public, the targeted stocks have already jumped higher.

• [By Teresa Rivas]

  DuPont (DD) slipped on Thursday after its first quarter missed analysts��estimates.

  The conglomerate said it earned $1.44 billion or $1.54 a share; excluding one-time items, per-share earnings were $1.58 a share, up two cents from the year-ago period but a penny below the $1.59 consensus.

  Revenue slipped 2.7% to $10.1 billion, also below the $10.45 analysts were expecting.

  The company noted that the extraordinarily harsh winter in many parts of the country hurt the results, to the tune of seven cents a share, as farmers delayed buying seeds and other agricultural products. Political uncertainty also disrupted sales in Ukraine, one of the world�� largest corn and wheat exporters.

  S&P Capital IQ�� Christopher Muir was downbeat about the prospect of DuPont�� outlook improving in the near term, lowering his rating on the stock to Sell from Hold, and lowered his target price by $1 to $64. ��e negatively view the 3.4% year-over-year drop in sales, though the drop was more than offset by strong cost control efforts. Q1 recurring EPS of $1.58, vs. $1.56, missed our $1.76 estimate and the $1.59 Capital IQ consensus. The shares are yielding 2.7%.

  By contrast, Citigroup�� P.J. Juvekar reiterated a Buy rating and $78 price target, noting that the company executes as well as could be expected in poor weather conditions, and that its full-year guidance and share repurchase plan are positives: ��D reported 1Q14 EPS of $1.58 vs. our $1.56 and consensus of $1.58. The company explicitly called out a 7c/share impact from adverse weather conditions in 1Q, reflecting a combination of higher operating costs and lost sales. 2014 EPS guidance of $4.20-$4.45 was reaffirmed, with an estimated 70% of FY14 EPS expected in 1H. DD repurchased ~$1B of stock in 1Q, more than we anticipated, and is well-positioned to complete the targeted $2B of stock this year. The Perf Chemicals separation is on track for mid-2015, with physical separation o

Top 10 Long Term Companies To Watch In Right Now: Duckwall-Alco Stores Inc.(DUCK)

Duckwall-ALCO Stores, Inc. operates as a regional broad line retailer in the central United States. The company operates ALCO stores that offer a line of merchandise consisting of approximately 35,000 items, including automotive, commodities, crafts, domestics, electronics, furniture, hardware, health and beauty aids, housewares, jewelry, pre-recorded music and video, sporting goods, seasonal items, stationery, and toys, as well as ladies?, men?s, and children?s apparel and shoes. As of March 1, 2012, it operated 216 ALCO stores in 23 states. The company was founded in 1901 and is based in Abilene, Kansas.

Advisors' Opinion:

• [By Geoff Gannon]

  Stocks trading at or below book value ��not counting goodwill ��are the easiest to understand. Whether we are talking about DreamWorks or Avalon Holdings or Duckwall ALCO (DUCK) or J.W. Mays (MAYS), if a stock is trading around book value your next step is to figure out how book value is calculated.

Top 10 Long Term Companies To Watch In Right Now: EV Energy Partners LP (EVEP)

EV Energy Partners, L.P. (the Partnership) is engaged in the acquisition, development and production of oil and natural gas properties. As of December 31, 2011, the Company's properties were located in the Barnett Shale, the Appalachian Basin (which includes the Utica Shale), the Mid Continent areas in Oklahoma, Texas, Arkansas, Kansas and Louisiana, the San Juan Basin, the Monroe Field in Northern Louisiana, the Permian Basin, Central and East Texas (which includes the Austin Chalk area), and Michigan. On November 1, 2011, the Company acquired oil and natural gas properties in the Mid Continent area. On December 1, 2011, the Company along with certain institutional partnerships managed by EnerVest, acquired oil and natural gas properties in the Barnett Shale. It acquired a 31.02% proportional interest in these properties. On December 20, 2011, the Company, along with certain institutional partnerships managed by EnerVest, acquired additional oil and natural gas properties in the Barnett Shale. It acquired a 31.63% proportional interest in these properties. On February 7, 2012, the Company along with certain institutional partnerships managed by EnerVest, had a second closing on the oil and natural gas properties, and acquired a 31.63% proportional interest in these properties.

Barnett Shale

The Barnett Shale properties are located in Denton, Parker, Tarrant and Wise counties in Northern Texas. Its portion of the estimated net proved reserves as of December 31, 2011, was 647.4 one billion cubic feet equivalent (Bcfe), 72% of which is natural gas. During 2011, the Company drilled 35 wells. EnerVest operates wells representing 100% of its estimated net proved reserves in this area, and the Company owns an average 29% working interest in 976 gross productive wells.

Appalachian Basin

The Company�� activities are concentrated in the Ohio and West Virginia areas of the Appalachian Basin. Its Ohio area properties are producing from the Knox and Clinton f! ormations and other Devonian age sands in 41 counties in Eastern Ohio and 11 counties in Western Pennsylvania. Its West Virginia area properties are producing from the Balltown, Benson and Big Injun formations in 23 counties in North Central West Virginia. Its estimated net proved reserves as of December 31, 2011, were 126.4 Bcfe, 76% of which is natural gas. During 2011, it drilled 33 grosswells, 26 of which were completed. EnerVest operates wells representing 92% of its estimated net proved reserves in this area, and it owns an average 41% working interest in 8,670 gross productive wells.

Mid-Continent Area

The properties are located in 47 counties in Oklahoma, 17 counties in Texas, four parishes in North Louisiana, one county in Kansas and six counties in Arkansas. The Company�� estimated net proved reserves as of December 31, 2011, were 81.2 Bcfe, 63% of which is natural gas. During 2011, it drilled 82 wells, all of which were completed. EnerVest operates wells representing 33% of its estimated net proved reserves in this area, and it owns an average 12% working interest in 1,864 gross productive wells.

San Juan Basin

The properties are located in Rio Arriba County, New Mexico and La Plata County in Colorado. The Company�� estimated net proved reserves as of December 31, 2011, 68.6 Bcfe, 59% of which is natural gas. During 2011, it drilled two wells, one of which were completed. EnerVest operates wells representing 94% of its estimated net proved reserves in this area, and it owns an average 71% working interest in 227 gross productive wells.

Monroe Field

The properties are located in two parishes in Northeast Louisiana. The Company�� estimated net proved reserves as of December 31, 2011, were 60.9 Bcfe, 100% of which is natural gas. During 2011, it drilled one well, which was completed. EnerVest operates wells representing 100% of its estimated net proved reserves in this area, and it owns an average 100% working i! nterest i! n 3,930 gross productive wells.

Permian Basin

The properties are located in the Yates, Seven Rivers, Queen, Morrow, Clear Fork and Wichita Albany formations in four counties in New Mexico and Texas. The Company�� estimated net proved reserves as of December 31, 2011, were 54.1Bcfe, 37% of which is natural gas. During 2011, it did not drill any wells. EnerVest operates wells representing 99% of its estimated net proved reserves in this area, and it owns an average 93% working interest in 160 gross productive wells.

Central and East Texas

The properties produce primarily from the Austin Chalk formation and are located in 30 counties in Central and East Texas. Its portion of the estimated net proved reserves as of December 31, 2011 was 60.9 Bcfe, 46% of which is natural gas. During 2011, the Company drilled 16 gross wells, 15 of which were completed. EnerVest operates wells representing 93% of its estimated net proved reserves in this area, and it owns an average 12% working interest in 1,829 gross productive wells.

Michigan

The properties are located in the Antrim Shale reservoir in Otsego and Montmorency counties in northern Michigan. The Company�� estimated net proved reserves as of December 31, 2011, were 44.9 Bcfe, 100% of which is natural gas. During 2011, it did not drill any wells. EnerVest operates wells representing 99% of its estimated net proved reserves in this area, and it has an average 84% working interest in 370 gross productive wells.

Advisors' Opinion:

• [By Matt DiLallo]

  The big problem is that there aren't a lot of buyers, which is the issue that�EV Energy Partners� (NASDAQ: EVEP  ) has run into with its own Utica sale. With major players like Chesapeake and Devon exiting, and foreign buyers like Sinopec already securing a foothold in the play, there are few buyers left that are willing to risk capital on a play that's no longer viewed as a sure thing. This has left EV Energy stuck with the 100,000 net acres it has been marketing since last year. The company has chosen to change its marketing strategy to sell the acreage in smaller packages to appeal to more buyers.�

• [By Arjun Sreekumar]

  Analysts expect some $2 billion worth of new projects to be revealed, in addition to the $2 billion of projects that have already been announced.�Major projects that have either been proposed or are under way include a natural gas liquids processing plant�by affiliates of NiSource and Hilcorp Energy; a gathering and processing plant by M3 Midstream LLC, Access Midstream Partners, and EV Energy Partners (NASDAQ: EVEP  ) ; and a proposed pipeline from Ohio to Detroit and Canada, to be built by DTE Energy, Spectra Energy (NYSE: SE  ) and Enbridge.

• [By Matt DiLallo]

  Investors in oil and gas MLP EV Energy Partners (NASDAQ: EVEP  ) have endured a very rough year. The company's units have been cut by nearly a third since the year started. With units now trading at a much lower price, let's look at three reasons why you might want to add these units to your portfolio.